Is Cyanocobalamin + Pyridoxine + Thiamine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 13 valid registrations of Cyanocobalamin + Pyridoxine + Thiamine, including 3V AMPOULES (100,100,1000 mg,mg,µg, Solution for injection, SAR 8.60); 3V TABLETS (200,100,200 mg,mg,µg, Film-coated tablet, SAR 12.40); NEURO-B FILM COATED TABLETS (100,100,0.15 mg,mg,mg, Film-coated tablet, SAR 13.45); NEUROBION ampoules (100,100,1 mg,mg,mg, Solution for injection, SAR 13.65); NEUROBION ampoules (100,100,1000 mg,mg,µg, Solution for injection, SAR 45.50).

Active substances

Cyanocobalamin + Pyridoxine + Thiamine

SFDA 16

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
3V AMPOULES	100,100,1000 mg,mg,µg	Solution for injection · Intramuscular use	3 Ampoule	SAR 8.60	Generic · Prescription	Gulf Pharmaceutical Industries (Julphar)	Valid
3V TABLETS	200,100,200 mg,mg,µg	Film-coated tablet · Oral use	20 Blister	SAR 12.40	Generic · OTC	Gulf Pharmaceutical Industries (Julphar)	Valid
NEURO-B FILM COATED TABLETS	100,100,0.15 mg,mg,mg	Film-coated tablet · Oral use	20 Blister	SAR 13.45	Generic · OTC	Tabuk Pharmaceutical Manufacturing Company	Valid
NEUROBION ampoules	100,100,1 mg,mg,mg	Solution for injection · Intramuscular use	3 Ampoule	SAR 13.65	NCE · Prescription	P&G Health GmbH	Valid
NEUROBION ampoules	100,100,1000 mg,mg,µg	Solution for injection · Intramuscular use	10 Ampoule	SAR 45.50	NCE · Prescription	P&G Health GmbH	Valid
NEUROBION tablet	200,100,200 mg,mg,µg	Coated tablet · Oral use	20 Blister	SAR 15.85	NCE · OTC	P&G Health GmbH	Valid
NEUROBION tablet	200,100,200 mg,mg,µg	Coated tablet · Oral use	30 Blister	SAR 23.30	NCE · OTC	P&G Health GmbH	Valid
NEURORUBINE SOLUTION	100,100,1 mg,mg,mg	Solution for injection · Intramuscular use	5 Ampoule	SAR 12.90	Generic · Prescription	ACINO PHARMA AG	Valid
NEURORUBINE-FORTE	200,50,1 mg,mg,mg	Film-coated tablet · Oral use	30 Blister	SAR 12.05	Generic · OTC	ACINO PHARMA AG	Valid
NEUROVIT AMPOULES	150,100,1 mg,mg,mg	Injection · Intramuscular and intravenous use	3 Ampoule	SAR 9.85	NCE · Prescription	ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES	Valid
NEUROVIT tablet	250,100,250 mg,mg,µg	Coated tablet · Oral use	20 Blister	SAR 10.00	Generic · OTC	ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES	Valid
Neurovit	100,250,250 mg,mg,µg	Tablet · Oral use	30 Blister	SAR 15.00	Generic · Prescription	AMRIYA FOR PHARMACEUTICAL INDUSTRIES	Valid
TRIPLEX B FILM COATED TABLET	200,100,200 mg,mg,µg	Film-coated tablet · Oral use	30 Blister	SAR 19.80	Generic · OTC	Jamjoom Pharmaceuticals Factory Company	Valid
B COMPLETE AMPOULE	35 , 35 , 0.38 mg/ml	Solution · Intramuscular use	5 Ampoule	SAR 12.90	Generic · Prescription	Jazeera Pharmaceutical Industries (JPI)	Withdrawn by MAH · Not Marketed
NEUROCOMB I.M INJECTION	100,100,1000 mg,mg,µg	Solution for injection · Intramuscular use	3 Ampoule	SAR 15.90	Generic · Prescription	Jamjoom Pharmaceuticals Factory Company	Withdrawn by MAH · Not Marketed
SOPALAMIN 3B VIAL	100,100,1000 mg,mg,µg	Solution · Intramuscular use	3 Vial	SAR 17.65	NCE · Prescription	SOBARA	Invalid · Not Marketed

Indications — CHI Daman Drug Formulary

BARIATRIC SURGERY

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.